What is it about?
Because of the antibiotic resistance development over the past half-century, the options for antimicrobial therapy in shigellosis are limited to a small number of drugs. Over time, the antimicrobial resistance patterns of Shigella spp. have changed according to geographical locations and the treatment process became more complicated.
Why is it important?
We conclude that Shigella spp. can be considered as an etiological agent of diarrhoea with a high level of antibiotic resistance in Ahvaz, Iran.
Read the Original
This page is a summary of: Prevalence and antimicrobial resistance of Shigella species isolated from diarrheal patients in Ahvaz, southwest Iran, Infection and Drug Resistance, January 2019, Dove Medical Press, DOI: 10.2147/idr.s187861.
You can read the full text:
The following have contributed to this page